Trial Profile
Observational Study in Everyday Medical Practice of the Effectiveness of Telmisartan for Treatment of Isolated Systolic Hypertension in Comparison With Systolic/Diastolic Hypertension in Patients Aged 55 or Older
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 24 Sep 2014
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary) ; Telmisartan/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 24 Sep 2014 New trial record